Ligand profile
CZA
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_1980 — HAD ATPase, P-type, IC family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
CZA- PDB
5mpm- UniProt (similar protein)
P11607-2- Target protein
- VK055_1980
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 73.4
- −1 ≤ LogP ≤ 5 2.83
- MW ≤ 500 Da 336.4
- LogP ≤ 5 2.83
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 73.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=O)C1=C(N2[C@H](C1=O)[C@H]3c4c[nH]c5c4c(ccc5)C[C@H]3C2(C)C)OCC(=O)C1=C(N2[C@H](C1=O)[C@H]3c4c[nH]c5c4c(ccc5)C[C@H]3C2(C)C)O
InChI=1S/C20H20N2O3/c1-9(23)14-18(24)17-16-11-8-21-13-6-4-5-10(15(11)13)7-12(16)20(2,3)22(17)19(14)25/h4-6,8,12,16-17,21,25H,7H2,1-3H3/t12-,16+,17+/m1/s1InChI=1S/C20H20N2O3/c1-9(23)14-18(24)17-16-11-8-21-13-6-4-5-10(15(11)13)7-12(16)20(2,3)22(17)19(14)25/h4-6,8,12,16-17,21,25H,7H2,1-3H3/t12-,16+,17+/m1/s1
RLOAZVAJNNPPDI-DQYPLSBCSA-NRLOAZVAJNNPPDI-DQYPLSBCSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00122' 'PF00690
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand CZA →
- PDB RCSB structure 5mpm →
- UniProt UniProt P11607-2 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CZA”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1980.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 5
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).